Part 1 - Welcome Address by Dr Shikha Varma
Part 2 - Introduction - Dr. M B Agarwal, Mumbai
Part 3 - Managing CML with co-morbidities - Dr. Tuphan Dolai, Kolkata
Part 4 - Long-term results of Dasatinib in front line therapy of CML - Dr Chandrakala S, Mumbai
Part 5 - 1-G or 2-G TKI for CML-CP at diagnosis: Which is better? - Dr. Kishore Kumar, Chennai
Part 6 - Use of generic imatinib - Dr. Punit Jain, Mumbai
Part 7 - Extramedullary blast crisis of CML - Dr. K S Natraj, Bangalore
Part 8 - Concluding remarks - Dr. M B Agarwal, Mumbai
Part 9 - Vote of Thanks - Dr. Shikha Verma, Lupin Oncology